What edge cases trip up point-of-sale systems in pharmaceuticals and biotech, think of temperature excursion?

In pharmaceuticals and biotech watch for: temperature excursion; batch recall; short-dated stock. A system that cannot handle these will frustrate the business; the catalog's failsafe items address some generic cases.

Go to the related page

How to read this

The tag above says how real the answer is. Answers describe the plan in the repository and design documents. No app is released. Where an answer touches tax or law, treat it as a theme to verify with a qualified local adviser.

More in Health care

• What is missing in Simca's plan for pharmaceuticals and biotech, think of no manufacturing execution, batch-record or quality systems?
• What rules should pharmaceuticals and biotech check locally, for example good-manufacturing-practice and pharmacovigilance regimes?
• Which reports matter most in pharmaceuticals and biotech, for example batch genealogy?
• See it in context with the whole topic
• Search all answers